SNX6 (N-term), 81-110 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-SNX6 (N-term), 81-110 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | SNX6 (N-term), 81-110 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human (predicted reactivity: mouse) |
| Isotype | n/a |
| Format | purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 2 |
| Applications | Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This SNX6 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 81-110 amino acids from the N-terminal region of human SNX6. SNX6 interacts with members of the transforming growth factor-beta family of receptor serine-threonine kinases. These receptors belong to two classes: type II receptors that bind ligand, and type I receptors that are subsequently recruited to transduce the signal. Of the type II receptors, SNX6 was found to interact strongly with ActRIIB and more moderately with wild type and kinase-defective mutants of TbetaRII. Of the type I receptors, SNX6 was found to interact only with inactivated TbetaRI. SNXs 1-4 also interacted with the transforming growth factor-beta receptor family, sho |
| Immunogen | n/a |
| Other Names | [Sorting nexin-6; TRAF4-associated factor 2; Sorting nexin-6; N-terminally processed; SNX6] |
| Gene, Accession # | [SNX6], Gene ID: 58533, NCBI: NP_067072.3, UniProt: Q9UNH7 |
| Catalog # | MBS9210793 |
| Price | $165, $370 |
| Order / More Info | SNX6 (N-term), 81-110 Antibody from MYBIOSOURCE INC. |
| Product Specific References | Parks W.T., J. Biol. Chem. 276:19332-19339(2001). |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies